2026 Richard A. Scolyer: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	137	1874	1746	57	54	1115	89495

Research.com Recognitions

2023 - Research.com Medicine in Australia Leader Award
2017 - Fellow of the Australian Academy of Health and Medical Science

Overview

Richard A. Scolyer is affiliated with the Royal Prince Alfred Hospital in Australia. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Oncology, Molecular Biology, Immunology, Cancer Research, and Epidemiology.

The scientist's work addresses several main topics, including:

Cutaneous Melanoma Detection and Management
Cancer Immunotherapy and Biomarkers
Melanoma and MAPK Pathways
Immunotherapy and Immune Responses
CAR-T cell therapy research
Cancer Genomics and Diagnostics
Nonmelanoma Skin Cancer Studies

Scolyer has contributed to multiple recent publications. Notable papers include:

"Cutaneous melanoma" (2023) published in The Lancet
"The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway" (2020) published in Archives of Pathology & Laboratory Medicine
"Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)" (2021) published in Nature Medicine
"Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma" (2024) published in New England Journal of Medicine
"Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma" (2021) published in Nature Medicine

The scientist has collaborated frequently with colleagues such as Georgina V. Long, Serigne Lo, John F. Thompson, Alexander M. Menzies, and James S. Wilmott. These collaborations are reflected across numerous publications.

Scolyer's works have appeared in various academic venues, most prominently:

Journal of Clinical Oncology
Pathology
Annals of Oncology
Cancer Research
Annals of Surgical Oncology

In addition to journal articles, the scientist has published books, including "Melanocytic Tumors of the Skin" (2024) with American Registry of Pathology Arlington, Virginia eBooks.

Richard A. Scolyer was recognized as a Fellow of the Australian Academy of Health and Medical Science in 2017.

Best Publications

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

3193
Citations
Pan-cancer analysis of whole genomes

Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

3090
Citations
Genomic Classification of Cutaneous Melanoma

Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

3009
Citations
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

2565
Citations
Comprehensive Characterization of Cancer Driver Genes and Mutations.

Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

2512
Citations
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Jeffrey E. Gershenwald;Richard A. Scolyer;Kenneth R. Hess;Vernon K. Sondak

2058
Citations
Whole-genome landscapes of major melanoma subtypes

Nicholas K. Hayward;Nicholas K. Hayward;James S. Wilmott;Nicola Waddell;Nicola Waddell;Peter A. Johansson

1492
Citations
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma

Georgina V. Long;Alexander M. Menzies;Adnan M. Nagrial;Lauren E. Haydu

1217
Citations
Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

1116
Citations
Patterns of somatic structural variation in human cancer genomes

Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

942
Citations
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study

Georgina V Long;Victoria Atkinson;Serigne Lo;Shahneen Sandhu

917
Citations
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma

Christine Guo Lian;Yufei Xu;Craig Ceol;Craig Ceol;Feizhen Wu

892
Citations
Pathogenic Germline Variants in 10,389 Adult Cancers

Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

848
Citations
Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma

Farhad Azimi;Richard A. Scolyer;Pavlina Rumcheva;Marc Moncrieff

827
Citations
Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance.

Hubing Shi;Gatien Moriceau;Xiangju Kong;Mi Kyung Lee

771
Citations
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

Tuba N. Gide;Camelia Quek;Alexander M. Menzies;Annie T. Tasker

730
Citations
Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma

James Samuel Wilmott;Georgina V. Long;Julie R. Howle;Julie R. Howle;Lauren E. Haydu

679
Citations
A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention

Andrew C. Chen;Andrew J. Martin;Bonita Choy;Pablo Fernández-Peñas

607
Citations
Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

589
Citations
BRAF inhibitor resistance mechanisms in metastatic melanoma; spectrum and clinical impact.

Helen Rizos;Alexander M. Menzies;Gulietta M. Pupo;Matteo S. Carlino

562
Citations

Frequent Co-Authors

John F. Thompson University of Sydney

Georgina V. Long University of Sydney

James S. Wilmott University of Sydney

Alexander M. Menzies University of Sydney

Richard F. Kefford Macquarie University

Graham J. Mann Australian National University

Helen Rizos Macquarie University

Matteo S. Carlino University of Sydney

Nicholas K. Hayward QIMR Berghofer Medical Research Institute

Peter Hersey University of Sydney

External Links

Personal website of Richard A. Scolyer

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring alternative or complementary paths to a traditional medical degree can help you broaden your impact in healthcare. For those interested in diet, disease prevention, and wellness, consider earning a nutrition bachelor degree online. This flexible option prepares graduates for diverse roles in public health, research, or clinical settings.

Accreditation is an important factor when selecting any healthcare program. If you are pursuing healthcare administration, be sure to explore which online healthcare degree programs are recognized for their accreditation by cahme. This ensures your degree is valued by employers and meets industry standards.

Registered nurses looking to advance their qualifications may benefit from online rn to bsn programs without clinical requirements. These programs provide a convenient way to obtain a BSN while balancing work and life commitments.

For those seeking advanced practice roles, accelerated msn to dnp programs allow for a rapid transition to the highest level of nursing practice and leadership. Consider your career goals and choose pathways that best fit your aspirations within the healthcare sector.